FYI - I'm not a newbie. I have a significant holding, with my initial purchase at 33 cents, or thereabouts.
I am well aware of the history of the company, both good and bad, and our Phase 3 approval was not without its hiccups. That eventual approval doesn't mean the people involved are the right ones to keep moving this in the direction it needs to go.
Biotechs are notoriously rocky, but at Phase 3, a floor price should hold, and it isn't.
4 months since Phase 3 Green light, page-10
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.5¢ | $189.9K | 940.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 436602 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 332703 | 5 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |